Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. 2005, 15, 30208. Cleator, J.H.
Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. 2005, 15, 30208. Cleator, J.H.; Qin Zhu, W.; Vaughan, D.E.; Hamm, H.E. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated K-Ras drug receptors and cAMP. Blood 2006, 107, 2736744. Sen, U.; Tyagi, N.; Patibandla, P.K.; Dean, W.L.; Tyagi, S.C.; Roberts, A.M.; Lominadze, D. Fibrinogen-induced endothelin-1 production from endothelial cells. Am. J. Physiol. Cell Physiol. 2009, 296, C840 847. OkruhlicovL’.; Dlugosov K.; Mitasikov M.; Bern, I. Ultrastructural qualities of , tovaortic endothelial cells in borderline hypertensive rats exposed to chronic social stress. Physiol. Res. 2008, 57, S31 37. Davis, J.S.; Yeo, T.W.; Piera, K.A.; Woodberry, T.; Celermajer, D.S.; Stephens, D.P.; Anstey, N.M. Angiopoietin-2 is increased in sepsis and inversely related to nitric oxide-dependent microvascular reactivity. Crit. Care 2010, 14, R89. Yeo, T.W.; Lampah, D.A.; Tjitra, E.; Piera, K.; Gitawati, R.; Kenangalem, E.; Price tag, R.N.; Anstey, N.M. Higher endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: A prospective study in Papua, Indonesia. J. Infect. Dis. 2010, 202, 10912. Vischer, U.; Barth, H.; Wollheim, C. Regulated von Willebrand factor secretion is linked to agonist-specific patterns of cytoskeletal remodelling in cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 88391. Nightingale, T.; White, I.; Doyle, E.; Turmaine, M.; Harrison-Lavoie, K.; Webb, K.; Cramer, L.P.; Cutler, D.F. Actomyosin II contractility expels von Willebrand aspect from Weibel-Palade bodies during exocytosis. J. Cell Biol. 2011, 194, 61329. Geleijnse, J.M.; Giltay, E.J.; Grobbee, D.E.; Donders, A.R.T.; Kok, F.J. Blood stress response to fish oil supplementation: HIV list Metaregression evaluation of randomized trials. J. Hypertens. 2002, 20, 1493499. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E following myocardial infarction: Benefits in the GISSI-Prevenzione trial. Lancet 1999, 354, 44755. Bnaa, K.; Bjerve, K.; Straume, B.; Gram, I.; Thelle, D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension–A population-based intervention trial from the Troms tudy. N. Engl. J. Med. 1990, 322, 79501.Mar. Drugs 2013,18. Mori, T.; Bao, D.; Burke, V.; Puddey, I.; Beilin, L. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999, 34, 25360. 19. Morris, M.; Sacks, F.; Rosner, B. Does fish oil lower blood stress A meta-analysis of controlled trials. Circulation 1993, 88, 52333. 20. De Caterina, R.; Cybulsky, M.; Clinton, S.; Gimbrone, M.; Libby, P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1994, 14, 1829836. 21. Stulnig, T.M.; Huber, J.; Leitinger, N.; Imre, E.M.; Angelisova, P.; Nowotny, P.; Waldhausl, W. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 2001, 276, 373357340. 22. Webb, Y.; Hermida-Matsumoto, L.; Resh, M.D. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J. Biol. Chem. 2000, 275, two.